chloroquine has been researched along with pseudoginsenoside f11 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, DM; Liu, YL; Liu, YY; Sun, SB; Wu, CF; Xu, HS; Xue, X; Yang, HL; Yang, JY; Yuan, LL; Zhang, C; Zhang, HT; Zhang, TY | 1 |
1 other study(ies) available for chloroquine and pseudoginsenoside f11
| Article | Year |
|---|---|
Pseudoginsenoside-F11 attenuates cerebral ischemic injury by alleviating autophagic/lysosomal defects.
Topics: Animals; Apoptosis; Autophagy; Brain; Brain Edema; Brain Ischemia; Chloroquine; Disease Models, Animal; Ginsenosides; Lysosomes; Male; Neuroglia; Neurons; Neuroprotective Agents; Rats, Sprague-Dawley; Stroke | 2017 |